Literature DB >> 29075857

Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

V Polenta1,2, E P Slater3, P H Kann4, M B Albers3, J Manoharan3, A Ramaswamy5, A H Mahnken6, D K Bartsch3.   

Abstract

BACKGROUND: Radiological tumor size of non-functioning pancreatic neuroendocrine neoplasms (Nf-pNENs) associated with multiple endocrine neoplasia type 1 (MEN1) is a crucial parameter to indicate surgery. The aim of this study was to compare radiological size (RS) and pathologic size (PS) of MEN1 associated with pNENs.
METHODS: Prospectively collected data of MEN1 patients who underwent pancreatic resections for pNENs were retrospectively analyzed. RS was defined as the largest tumor diameter measured on endoscopic ultrasound (EUS), magnetic resonance imaging (MRI) or computed tomography (CT). PS was defined as the largest tumor diameter on pathological analysis. Student's t test and linear regression analysis were used to compare the median RS and PS. p < 0.05 was considered significant.
RESULTS: Forty-four patients with a median age of 37 (range 10-68) years underwent primary pancreatic resections for pNENs. Overall, the median RS (20 mm, range 3-100 mm) was significantly larger than the PS (13 mm, range 4-110 mm) (p = 0.001). In patients with pNENs < 20 mm (n = 27), the size difference (median RS 15 mm vs PS 12 mm) was also significant (p = 0.003). However, the only modality that significantly overestimated the PS was EUS (median RS 14 mm vs 11 mm; p = 0.0002). RS overestimated the PS in 21 patients (21 of 27 patients, 78%). Five of 11 patients (12%) with a Nf-pNEN and a RS > 20 mm had in reality a PS < 20 mm. MRI was the imaging technique that best correlated with PS in the total cohort (r = 0.8; p < 0.0001), whereas EUS was the best correlating imaging tool in pNENs < 20 mm (r = 0.5; p = 0.0001).
CONCLUSION: Preoperative imaging, especially EUS, frequently overestimates the size of MEN1-pNENs, especially those with a PS < 20 mm. This should be considered when indicating surgery in MEN1 patients with small Nf-pNENs.

Entities:  

Mesh:

Year:  2018        PMID: 29075857     DOI: 10.1007/s00268-017-4317-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  42 in total

Review 1.  Multiple endocrine neoplasia type 1.

Authors:  M L Brandi
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Lethality of multiple endocrine neoplasia type I.

Authors:  G M Doherty; J A Olson; M M Frisella; T C Lairmore; S A Wells; J A Norton
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

Review 3.  Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.

Authors:  Alexander D J Baur; Marianne Pavel; Vikas Prasad; Timm Denecke
Journal:  Acta Radiol       Date:  2015-04-08       Impact factor: 1.990

4.  Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Laurence Thomas-Marques; Arnaud Murat; Brigitte Delemer; Alfred Penfornis; Catherine Cardot-Bauters; Eric Baudin; Patricia Niccoli-Sire; Damien Levoir; Hélène du Boullay Choplin; Olivier Chabre; Nicolas Jovenin; Guillaume Cadiot
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Peter H Kann; Volker Fendrich; Gerd Richter; Saskia Diehl; Matthias Rothmund; Detlef K Bartsch
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

6.  Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.

Authors:  Jens Waldmann; Volker Fendrich; Nils Habbe; Detlef K Bartsch; Emily P Slater; Peter H Kann; Matthias Rothmund; Peter Langer
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

7.  Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life.

Authors:  Y Nancy You; Geoffrey B Thompson; William F Young; Dirk Larson; David R Farley; Melanie Richards; Clive S Grant
Journal:  Surgery       Date:  2007-12       Impact factor: 3.982

Review 8.  The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Authors:  Günter Klöppel; Aurel Perren; Philipp U Heitz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

9.  Discrepancy between radiological and pathological size of renal masses.

Authors:  Nicola N Jeffery; Norbert Douek; Ding Y Guo; Manish I Patel
Journal:  BMC Urol       Date:  2011-02-22       Impact factor: 2.264

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

View more
  5 in total

Review 1.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

2.  Can We Do Even Better? Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

Authors:  Chad G Ball
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

3.  Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.

Authors:  Kira Oleinikov; Inbal Uri; Harold Jacob; Julia Epshtein; Ariel Benson; Simona Ben-Haim; Karine Atlan; Ilanit Tal; Amichay Meirovitz; Ofra Maimon; Naama Lev-Cohain; Haggi Mazeh; Benjamin Glaser; David J Gross; Simona Grozinsky-Glasberg
Journal:  Endocrine       Date:  2020-02-08       Impact factor: 3.633

Review 4.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

5.  Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.

Authors:  Dirk-Jan van Beek; Helena M Verkooijen; Sjoerd Nell; Bert A Bonsing; Casper H van Eijck; Harry van Goor; Frederik J H Hoogwater; Elisabeth J M Nieveen van Dijkum; Geert Kazemier; Cornelis H C Dejong; Lodewijk A A Brosens; Frank J Wessels; Inne H M Borel Rinkes; Gerlof D Valk; Menno R Vriens
Journal:  Neuroendocrinology       Date:  2020-07-28       Impact factor: 4.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.